Middle East and Africa Melanoma Therapeutics Market by cancer stage (Stage 0, Stage I, Stage II, Stage III, Stage IV), by cancer type (Nodular melanoma, Acral lentiginous melanoma, Superficial spreading melanoma, Lentigno maligna melanoma, Amelanotic melanoma, Others), by diagnosis (Ultrasound, Blood Tests, Dermatoscopy, Sentinel lymph node biopsy, X-rays, CT Scan), by treatment (early melanoma, advanced melanoma-Biological therapy, Targeted therapy, Surgery, Chemotherapy, Radiotherapy, Immune therapy), and by Region- Industry Analysis, Size, Share, Growth, Trends, and Forecasts (2016–2021)

Middle East and Africa Melanoma Therapeutics Market by cancer stage (Stage 0, Stage I, Stage II, Stage III, Stage IV), by cancer type (Nodular melanoma, Acral lentiginous melanoma, Superficial spreading melanoma, Lentigno maligna melanoma, Amelanotic melanoma, Others), by diagnosis (Ultrasound, Blood Tests, Dermatoscopy, Sentinel lymph node biopsy, X-rays, CT Scan), by treatment (early melanoma, advanced melanoma-Biological therapy, Targeted therapy, Surgery, Chemotherapy, Radiotherapy, Immune therapy), and by Region- Industry Analysis, Size, Share, Growth, Trends, and Forecasts (2016–2021)

ID: 856 | Pages: 138 | November 2016 | Region: Middle East and Africa


The Middle East and Africa Melanoma Therapeutics Market was worth $0.13 billion in 2016 and estimated to be growing at a CAGR of 13.49%, to reach $0.24 billion by 2021. The melanoma market has seen an unmatched boost in market size due to the dynamically developing nature of melanoma treatments over the recent past.

Even though, a plethora of treatment choices are available today, various immunotherapies and combination therapies are anticipated to arrive in the market. Large scale acceptance of these new treatments is expected due to their enhanced survival benefits and minor side effects.

The growth of the Middle East and Africa Melanoma Therapeutics Market is mainly due to factors such as increase in number of melanoma cases, weather conditions in this region and rising awareness towards it. However, high costs associated with the treatment and lack of availability of appropriate cancer care in some countries in this region are the crucial factors deterring the growth of the market in this region.

The Middle East and Africa Melanoma Therapeutics market is segmented based on cancer stage, cancer type, diagnosis, and treatment. The market for Melanoma Therapeutics, on the basis of cancer stage is segmented into Stage 0, Stage I, Stage II, Stage III, Stage IV. On the basis of cancer type, the Melanoma Therapeutics market is segmented into Nodular melanoma, Acral lentiginous melanoma, Superficial spreading melanoma, Lentigno maligna melanoma, Amelanotic melanoma, and Others. On the basis of diagnosis, the Melanoma Therapeutics market is segmented into Ultrasound, Blood Tests, Dermatoscopy, Sentinel lymph node biopsy, X-rays, CT Scan. On the basis of treatment, the Melanoma Therapeutics market is segmented into early melanoma and advanced melanoma. Advanced melanoma is further sub-segmented into Biological therapy, Targeted therapy, Surgery, Chemotherapy, Radiotherapy, Immune therapy. X-rays leads the Melanoma Therapeutics market under the diagnosis segment, whereas chemotherapy leads the market under the treatment segment.

The market has been geographically segmented into Middle East and Africa. This market is projected to grow substantially during the forecast period due to the rising prevalence of melanoma in this region.

The major companies dominating the market in this region are Bristol-Myers Squibb Co., Merck and Co., F. Hoffmann-La Roche, Amgen Inc., Celgene Corp, Daiichi Sankyo, and Pfizer Inc.

1. Introduction                             

              1.1 Market Definition                  

              1.2 Study Deliverables                

              1.3 Base Currency, Base Year and Forecast Periods                       

              1.4 General Study Assumptions              

2. Research Methodology                                       

              2.1 Introduction                           

              2.2 Research Phases                    

                             2.2.1 Secondary Research          

                             2.2.2 Primary Research

                             2.2.3 Econometric Modelling     

                             2.2.4 Expert Validation 

              2.3 Analysis Design                      

              2.4 Study Timeline                       

3. Overview                                   

              3.1 Executive Summary              

              3.2 Key Inferences                       

              3.3 New Developments              

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                                

              4.1 Market Drivers                       

              4.2 Market Restraints                  

              4.3 Key Challenges                       

              4.4 Current Opportunities in the Market                           

5. Market Segmentation                                          

              5.1 By cancer stage                      

                             5.1.1 Stage 0     

                             5.1.2 Stage I      

                             5.1.3 Stage II     

                             5.1.4 Stage III   

                             5.1.5 Stage IV   

              5.2 By cancer type                        

                             5.2.1 Nodular melanoma           

                             5.2.2 Acral lentiginous melanoma          

                             5.2.3 Superficial spreading melanoma  

                             5.2.4 Lentigno maligna melanoma         

                             5.2.5 Amelanotic melanoma     

                             5.2.6 Others     

              5.3 By Diagnosis                           

                             5.3.1 Ultrasound            

                             5.3.2 Blood Tests           

                             5.3.3 Dermatoscopy      

                             5.3.4 Sentinel lymph node biopsy           

                             5.3.5 X-rays       

                             5.3.6 CT Scan    

              5.4 By Treatment                         

                             5.4.1 Early melanoma   

                             5.4.2 Advanced melanoma        

                                           5.4.2.1 Biological therapy

                                           5.4.2.2 Targeted therapy

                                           5.4.2.3 Surgery

                                           5.4.2.4 Chemotherapy

                                           5.4.2.5 Radiotherapy

                                           5.4.2.6 Immune therapy

6. Geographical Analysis                                         

              6.1 Introduction                           

              6.2 Middle-East                            

              6.3 Africa                         

7. Pipeline Product Analysis                                    

              7.1 Overview                                 

              7.2 Pipeline Development Landscape                                 

              7.3 Molecular Targets in the Pipeline                                  

              7.4 Clinical Trials                          

                             7.4.1 Failure Rate by Stage of Development, Indication, Molecule Type and Molecular Target    

                             7.4.2 Clinical Trial Duration by Stage of Development, Indication, Molecule Type and Molecular Target             

                             7.4.3 Clinical Trial Size by Stage of Development, Indication, Molecule Type and Molecular Target.   

8. Strategic Analysis                                   

              8.1 PESTLE analysis                      

                             8.1.1 Political    

                             8.1.2 Economic

                             8.1.3 Social       

                             8.1.4 Technological       

                             8.1.5 Legal         

                             8.1.6 Environmental     

              8.2 Porter’s Five analysis                          

                             8.2.1 Bargaining Power of Suppliers       

                             8.2.2 Bargaining Power of Consumers   

                             8.2.3 Threat of New Entrants    

                             8.2.4 Threat of Substitute Products and Services             

                             8.2.5 Competitive Rivalry within the Industry     

9. Market Leaders' Analysis                                    

              9.1 Bristol-Myers Squibb Co                     

                             9.1.1 Overview 

                             9.1.2 Product Analysis  

                             9.1.3 Strategic Evaluation and Operations          

                             9.1.4 Financial analysis 

                             9.1.5 Legal issues           

                             9.1.6 Recent Developments       

                             9.1.7 SWOT analysis      

                             9.1.8 Analyst View         

              9.2 Merck and Co                         

              9.3 F. Hoffmann-La Roche                        

              9.4 Amgen Inc                

              9.5 Celgene Corp                          

              9.6 Daiichi Sankyo                        

              9.7 Pfizer Inc                   

10. Competitive Landscape                                     

              10.1 Market share analysis                      

              10.2 Merger and Acquisition Analysis                  

              10.3 Agreements, collaborations and Joint Ventures                    

              10.4 New Product Launches                     

11. Expert Opinions                                   

              11.1 Market Outlook                   

              11.2 Investment Opportunities               

Appendix                                       

              a) List of Tables              

              b) List of Figures                           

  • Regional, and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms of technology, component, and type along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analysing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
TitlePriceAdd To Cart
  1. Middle East & Africa Melanoma Therapeutics Market By Region, From 2016-2021 (USD Billion)
  2. Middle East & Africa Melanoma Therapeutics Market By Cancer stage , From 2016-2021 (USD Billion)
  3. Middle East & Africa Stage 0 Market By Region, From 2016-2021 (USD Billion)
  4. Middle East & Africa Stage I Market By Region, From 2016-2021 (USD Billion)
  5. Middle East & Africa Stage II Market By Region, From 2016-2021 (USD Billion)
  6. Middle East & Africa Stage III Market By Region, From 2016-2021 (USD Billion)
  7. Middle East & Africa Stage IV Market By Region, From 2016-2021 (USD Billion)
  8. Middle East & Africa Melanoma Therapeutics Market By Cancer type , From 2016-2021 (USD Billion)
  9. Middle East & Africa Nodular melanoma Market By Region, From 2016-2021 (USD Billion)
  10. Middle East & Africa Acral lentiginous melanoma Market By Region, From 2016-2021 (USD Billion)
  11. Middle East & Africa Superficial spreading melanoma Market By Region, From 2016-2021 (USD Billion)
  12. Middle East & Africa Lentigno maligna melanoma Market By Region, From 2016-2021 (USD Billion)
  13. Middle East & Africa Amelanotic melanoma Market By Region, From 2016-2021 (USD Billion)
  14. Middle East & Africa Other cancers Market By Region, From 2016-2021 (USD Billion)
  15. Middle East & Africa Melanoma Therapeutics Market By Diagnosis, From 2016-2021 (USD Billion)
  16. Middle East & Africa Ultrasound Market By Region, From 2016-2021 (USD Billion)
  17. Middle East & Africa Blood Tests Market By Region, From 2016-2021 (USD Billion)
  18. Middle East & Africa Dermatoscopy Market By Region, From 2016-2021 (USD Billion)
  19. Middle East & Africa Sentinel lymph node biopsy Market By Region, From 2016-2021 (USD Billion)
  20. Middle East & Africa X-rays Market By Region, From 2016-2021 (USD Billion)
  21. Middle East & Africa CT Scan Market By Region, From 2016-2021 (USD Billion)
  22. Middle East & Africa Melanoma Therapeutics Market By Treatment, From 2016-2021 (USD Billion)
  23. Middle East & Africa early melanoma Market By Region, From 2016-2021 (USD Billion)
  24. Middle East & Africa advanced melanoma Market By Region, From 2016-2021 (USD Billion)
  25. Middle East & Africa Melanoma Therapeutics Market By Advanced Melanoma, From 2016-2021 (USD Billion)
  26. Middle East & Africa Biological therapy Market By Region, From 2016-2021 (USD Billion)
  27. Middle East & Africa Targeted therapy Market By Region, From 2016-2021 (USD Billion)
  28. Middle East & Africa Surgery Market By Region, From 2016-2021 (USD Billion)
  29. Middle East & Africa Chemotherapy Market By Region, From 2016-2021 (USD Billion)
  30. Middle East & Africa Radiotherapy Market By Region, From 2016-2021 (USD Billion)
  31. Middle East & Africa Immune therapy Market By Region, From 2016-2021 (USD Billion)
  32. Middle East Melanoma Therapeutics Market By Cancer stage , From 2016-2021 (USD Billion)
  33. Middle East Melanoma Therapeutics Market By Cancer type , From 2016-2021 (USD Billion)
  34. Middle East Melanoma Therapeutics Market By Diagnosis, From 2016-2021 (USD Billion)
  35. Middle East Melanoma Therapeutics Market By Treatment, From 2016-2021 (USD Billion)
  36. Middle East Melanoma Therapeutics Market By Advanced Melanoma, From 2016-2021 (USD Billion)
  37. Africa Melanoma Therapeutics Market By Cancer stage , From 2016-2021 (USD Billion)
  38. Africa Melanoma Therapeutics Market By Cancer type , From 2016-2021 (USD Billion)
  39. Africa Melanoma Therapeutics Market By Diagnosis, From 2016-2021 (USD Billion)
  40. Africa Melanoma Therapeutics Market By Treatment, From 2016-2021 (USD Billion)
  41. Africa Melanoma Therapeutics Market By Advanced Melanoma, From 2016-2021 (USD Billion)
Middle East And Africa Psychiatry Therapies Market By Type (Social Psychology, Abnormal Psychology, Biological Psychology And Other Types), By Type Of Medication (Antidepressants, Antipsychotics, Depressants, Anxiol...
Latin America Psychiatry Therapies Market By Type (Social Psychology, Abnormal Psychology, Biological Psychology And Other Types), By Type Of Medication (Antidepressants, Antipsychotics, Depressants, Anxiolytics, Mo...
Asia Pacific Psychiatry Therapies Market By Type (Social Psychology, Abnormal Psychology, Biological Psychology And Other Types), By Type Of Medication (Antidepressants, Antipsychotics, Depressants, Anxiolytics, Moo...
Europe Psychiatry Therapies Market By Type (Social Psychology, Abnormal Psychology, Biological Psychology And Other Types), By Type Of Medication (Antidepressants, Antipsychotics, Depressants, Anxiolytics, Mood Stab...
North America Psychiatry Therapies Market By Type (Social Psychology, Abnormal Psychology, Biological Psychology And Other Types), By Type Of Medication (Antidepressants, Antipsychotics, Depressants, Anxiolytics, Mo...
Psychiatry Therapies Market By Type (Social Psychology, Abnormal Psychology, Biological Psychology And Other Types), By Type Of Medication (Antidepressants, Antipsychotics, Depressants, Anxiolytics, Mood Stabilisers...
Middle East and Africa Home Healthcare Market by Product (Testing, Screening, & Monitoring Products, Therapeutic Products, Mobility Care Products) by Service (Rehabilitation Therapy Services, Infusion Therapy Servic...
Latin America Home Healthcare Market by Product (Testing, Screening, & Monitoring Products, Therapeutic Products, Mobility Care Products) by Service (Rehabilitation Therapy Services, Infusion Therapy Services, Unski...
Asia-Pacific Home Healthcare Market by Product (Testing, Screening, & Monitoring Products, Therapeutic Products, Mobility Care Products) by Service (Rehabilitation Therapy Services, Infusion Therapy Services, Unskil...
Europe Home Healthcare Market by Product (Testing, Screening, & Monitoring Products, Therapeutic Products, Mobility Care Products) by Service (Rehabilitation Therapy Services, Infusion Therapy Services, Unskilled Ca...
North America Home Healthcare Market by Product (Testing, Screening, & Monitoring Products, Therapeutic Products, Mobility Care Products) by Service (Rehabilitation Therapy Services, Infusion Therapy Services, Unski...
Home Healthcare Market by Product (Mobility Care Products ,Screening, & Monitoring Products, Testing, Therapeutic Products) by Service (Infusion Therapy Services, Rehabilitation Therapy Services, Unskilled Care Serv...

"We Think Through Different Layers, We Work Across Different Verticals."

Market Data Forecast, Inc.
2nd Floor, Lakeview Plaza, Kavuri Hills, Hyderabad, Telangana 500033, India.
+1-888-702-9626 (U.S. TOLL FREE)
contact@marketdataforecast.com


Subscribe To Our News Letter

Or follow us on social platform

© 2017 Market Data Forecast
All Rights Reserved.